+65 3158 9940
1300 798 820
+64 9801 0299
New findings from the landmark TAILORx study have revealed that the Oncotype DX Breast Cancer Assay is able to accurately identify the 70% of early breast cancer patients who can safely avoid chemotherapy, as well as the 30% of women for whom chemotherapy is optimal. This investigation was the largest adjuvant breast cancer treatment trial
Senate Inquiry Into Rare Cancer Survival June, 2017: A Senate Committee was appointed earlier this year, to examine why some cancers still have low survival rates. The Senate Select Committee into Funding for Cancers with Low Survival was established following concerns that there had been little to no improvement in the survival rates for some
Specialised Therapeutics delegates will attend the BIO International Convention, which returns to Boston Massachusetts this June. Hosted by the Biotechnology Innovation Organization (BIO), the event is designed to foster global biotechnology innovation by uniting the pharma industry with biotechnology companies, academic institutions, state biotechnology centres and related organisations. As in previous years, Specialised Therapeutics’ Business
SARAH-JANE TASKER | THE AUSTRALIAN| 5 APRIL, 2018 New Breast Cancer Drug Reduces Risk of Relapse Australians with breast cancer can apply to receive a drug that reduces the risk of cancer returning, under a special access program. Nerlynx is targeted for use in women with HER 2+ early breast cancer. One in four women
See below, ST Asia’s Company Update / Annual Report for 2017/18. To view this publication, move your mouse over the image below and click on the Fullscreen button in the top right corner to expand the window.
Our Philanthropic Heart: A Hall without Walls By Carlo Montagner and Bozena Zembrzuski It was three years ago that our family decided we wanted to give and support causes beyond our local community. After making this decision, we were made aware of the struggles facing the people of Timor-Leste. While this region is geographically
Breast Cancer Awareness Month We know that on average, 1 in 8 Australian women will develop breast cancer. To acknowledge Breast Cancer Awareness Month, we share the story of Paula Beevor, who became the ‘one’ and decided to chase her dream of a new life in Australia. This is her story. To read full text,
ST is a longstanding supporter of the GI Cancer Institute, which saves lives by funding important research into gastro-intestinal cancers, including pancreatic cancer. In a few days, medical oncologist Dr Lorraine Chantrill will walk the Larapinta Trail in the Northern Territory to raise new funds. In this short video, she explains her mission and motivation.
Wendy Dunstone was diagnosed with early breast cancer and chose to have her tumour tested using the genomic test, Oncotype DX to guide decisions on her treatment. 59 year old Wendy was preparing to embark on the ‘trip of a lifetime’ when a routine breast screening revealed a hidden tumour. “I was feeling the healthiest
Linda Wilson is an Australian mother, wife, grandmother and nurse who was diagnosed with pancreatic cancer five years ago. She had surgery, but was devastated when her cancer recurred. While she was given just months to live, she has steadfastly refused to abandon hope. She says, “I don’t consider I am dying from pancreatic cancer,